Alivus Life Sciences informs about press release

23 Jan 2025 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Alivus Life Sciences has informed that it enclosed the Press Release on the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Alivus Life Sciences Share Price

925.20 37.50 (4.22%)
28-Jan-2026 10:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.00
Dr. Reddys Lab 1227.50
Cipla 1319.55
Zydus Lifesciences 888.05
Lupin 2127.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×